Up-front mutation detection in circulating tumor DNA by droplet digital PCR has added diagnostic value in lung cancer

Identification of actionable mutations in advanced stage non-squamous non-small-cell lung cancer (NSCLC) patients is recommended by guidelines as it enables treatment with targeted therapies. In current practice, mutations are identified by next-generation sequencing of tumor DNA (tDNA-NGS), which r...

Descripción completa

Detalles Bibliográficos
Autores principales: Visser, Esther, de Kock, Remco, Genet, Sylvia, Borne, Ben van den, Soud, Maggy Youssef-El, Belderbos, Huub, Stege, Gerben, de Saegher, Marleen, ’t Westeinde, Susan van, Broeren, Maarten, Eduati, Federica, Deiman, Birgit, Scharnhorst, Volkher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679361/
https://www.ncbi.nlm.nih.gov/pubmed/36413862
http://dx.doi.org/10.1016/j.tranon.2022.101589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679361/
https://www.ncbi.nlm.nih.gov/pubmed/36413862
http://dx.doi.org/10.1016/j.tranon.2022.101589

Ejemplares similares